- Home
- SMSI vs LGVN Comparison
SMSI vs LGVN Comparison
Compare SMSI & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMSI
- LGVN
- Stock Information
- Founded
- SMSI 1982
- LGVN 2014
- Country
- SMSI United States
- LGVN United States
- Employees
- SMSI N/A
- LGVN N/A
- Industry
- SMSI Computer Software: Prepackaged Software
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- SMSI Technology
- LGVN Health Care
- Exchange
- SMSI Nasdaq
- LGVN Nasdaq
- Market Cap
- SMSI 24.7M
- LGVN 27.6M
- IPO Year
- SMSI 1995
- LGVN 2021
- Fundamental
- Price
- SMSI $0.76
- LGVN $1.56
- Analyst Decision
- SMSI Strong Buy
- LGVN Strong Buy
- Analyst Count
- SMSI 1
- LGVN 3
- Target Price
- SMSI $5.00
- LGVN $8.67
- AVG Volume (30 Days)
- SMSI 301.5K
- LGVN 201.8K
- Earning Date
- SMSI 05-07-2025
- LGVN 05-13-2025
- Dividend Yield
- SMSI N/A
- LGVN N/A
- EPS Growth
- SMSI N/A
- LGVN N/A
- EPS
- SMSI N/A
- LGVN N/A
- Revenue
- SMSI $20,555,000.00
- LGVN $2,392,000.00
- Revenue This Year
- SMSI $36.40
- LGVN $26.05
- Revenue Next Year
- SMSI $46.07
- LGVN $12.27
- P/E Ratio
- SMSI N/A
- LGVN N/A
- Revenue Growth
- SMSI N/A
- LGVN 237.38
- 52 Week Low
- SMSI $0.52
- LGVN $0.77
- 52 Week High
- SMSI $3.21
- LGVN $6.40
- Technical
- Relative Strength Index (RSI)
- SMSI 34.47
- LGVN 45.61
- Support Level
- SMSI $0.75
- LGVN $1.44
- Resistance Level
- SMSI $0.89
- LGVN $1.62
- Average True Range (ATR)
- SMSI 0.07
- LGVN 0.12
- MACD
- SMSI 0.01
- LGVN -0.02
- Stochastic Oscillator
- SMSI 28.33
- LGVN 25.00
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. It offers multi-platform, modular solutions such as SafePath; CommSuite; and ViewSpot. The company's only reportable segment is Wireless. Its Wireless segment sells to large wireless carriers, cable operators, and OEMs.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.